International Stem Cell (ISCO) Other Operating Expenses (2010 - 2026)

International Stem Cell (ISCO) has reported Other Operating Expenses for 17 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Operating Expenses rose 25.99% year-over-year to $1.4 million in Q2 2026; TTM through Jun 2026 was $4.9 million, a 6.07% increase from a year earlier, with the FY2025 full-year figure at $4.7 million, up 6.7% from the prior year.
• Other Operating Expenses was $1.4 million for Q2 2026 at International Stem Cell, up from $1.2 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $1.4 million in Q2 2026 and troughed at $758000.0 in Q2 2023.
• A 5-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses surged 34.43% in 2022 and decreased 18.4% in 2023, its largest moves.
• Over 5 years, Other Operating Expenses stood at $1.3 million in 2022, then declined by 18.4% to $1.0 million in 2023, then climbed by 16.62% to $1.2 million in 2024, then gained by 3.58% to $1.2 million in 2025, then advanced by 10.38% to $1.4 million in 2026.
• The last three Other Operating Expenses figures came in at $1.4 million (Q2 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.